Several molecular markers, such as IDH, EGFR, MGMT and phosphatase and tensin homologue, can affect the formulation and implementation of treatment strategies for patients with GBM and can well predict the prognosis of patients. The gene discussed is EGFR; the disease is glioblastoma.